Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
Children with COVID-19 may not show typical symptoms
Children infected with SARS-CoV-2 may not show typical symptoms such as fever, cough or dyspnea, according to a retrospective cohort study of more than 12,000 pediatric COVID-19 patients in the United States.
In new study, patients with MIS-A had broader organ involvement than previously noted
A small cohort of patients at a Tennessee hospital who met the criteria for multisystem inflammatory syndrome in adults experienced broader organ involvement and were less ill compared with patients in a previous report, researchers said.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: ‘Paradigm shift’ needed to improve building ventilation
In a recent paper published in Science, researchers argued for a “paradigm shift” in how policymakers and building engineers approach indoor air quality and health in order to reduce the spread of respiratory infections.
Breakthrough infections rare among first 101 million fully vaccinated people, CDC finds
CDC investigators identified just 10,262 breakthrough SARS-CoV-2 infections in 46 U.S. states as of April 30, when approximately 101 million Americans had been fully vaccinated, according to results published today in MMWR.
Moderna says COVID-19 vaccine effective in adolescents, readies FDA submission
Moderna said Tuesday that its COVID-19 vaccine was safe and “highly effective” in a phase 2/3 study among adolescents aged 12 to 17 years, offering a level of protection in the younger age group akin to that seen in adults.
CDC’s COVID-19 vaccine safety group reviews ‘few’ reports of myocarditis in young people
The CDC’s COVID-19 vaccine safety group recently reviewed what it said were “relatively few reports” of myocarditis among young recipients of the messenger RNA-based COVID-19 vaccines.
Trial supports tocilizumab in moderate-to-severe COVID-19-associated pneumonia
A follow-up analysis of the CORIMUNO-TOCI-1 randomized clinical trial showed that tocilizumab may be considered for treating patients with moderate-to-severe COVID-19-associated pneumonia and high C-reactive protein levels.
Birth region may predict time to TB diagnosis among foreign-born people in US
Researchers found an association between region of birth and time to diagnosis among foreign-born people in the U.S. with tuberculosis, suggesting that where a person was born may predict progression from latent TB to TB disease, they said.
Masks, ventilation upgrades lowered COVID-19 incidence in elementary schools
Mask requirements and upgrades to ventilation reduced the incidence of COVID-19 in Georgia elementary schools by up to almost half, data published in MMWR showed.
Putting COVID-19 vaccine reactions into perspective
Experts have worked to reassure people that the benefits of COVID-19 vaccination outweigh the risks, which primarily include short-lived reactions.
-
Headline News
Q&A: App ‘much better’ than physicians at diagnosing ear infections
November 04, 20244 min read -
Headline News
Q&A: ‘Highly charged’ political environment, election sources of stress for US adults
November 04, 20243 min read -
Headline News
AI stands to change cardiology practice, but guidance, evidence of benefit are needed
November 04, 20247 min read
-
Headline News
Q&A: App ‘much better’ than physicians at diagnosing ear infections
November 04, 20244 min read -
Headline News
Q&A: ‘Highly charged’ political environment, election sources of stress for US adults
November 04, 20243 min read -
Headline News
AI stands to change cardiology practice, but guidance, evidence of benefit are needed
November 04, 20247 min read